We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ISCO market cap is 728.2k. The company's latest EPS is USD -0.0164 and P/E is -5.49.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 9.47M | 7.13M | 7.18M | 8.18M | 7.79M |
| Operating Income | -5.73M | -2.82M | -1.92M | -183k | -663k |
| Net Income | -4.27M | -2.72M | -899k | -331k | -131k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 6.62M | 5.29M | 4.95M | 5.14M | 5.39M |
| Total Liabilities | 5.21M | 5.32M | 5.23M | 5.36M | 5.28M |
| Total Equity | -2.89M | -4.33M | -4.59M | -4.52M | -4.19M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1.4M | -341k | -1.3M | 332k | 929k |
| Investing | -494k | -108k | -45k | -11k | -83k |
| Financing | 1.3M | 654k | 824k | 250k | N/A |
| Market Cap | 728.2k |
| Price to Earnings Ratio | -5.49 |
| Price to Sales Ratio | 0.09 |
| Price to Cash Ratio | 0.45 |
| Price to Book Ratio | 6.38 |
| Dividend Yield | - |
| Shares Outstanding | 8M |
| Average Volume (1 week) | 2.83k |
| Average Volume (1 Month) | 11.24k |
| 52 Week Change | -9.03% |
| 52 Week High | 0.195 |
| 52 Week Low | 0.046 |
| Spread (Intraday) | 0.08 (48.54%) |
| Company Name | International Stem Cell Corporation (QB) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://internationalstemcell.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
